Corbus Pharmaceuticals Appoints Anne Altmeyer, PhD to Board of Directors

NORWOOD, Mass., Sept. 26, 2022 /PRNewswire/ — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), an immunology company, today announced the appointment of Anne Altmeyer, PhD, MBA, MPH to its board of directors. “Anne is a dynamic leader with a proven track…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.